Invivyd (IVVD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Voting matters and shareholder proposals
Six nominees are up for election to the board of directors for a one-year term expiring at the 2027 annual meeting.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is proposed.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
The board consists of six nominees: Tamsin Berry, Paul B. Bolno, M.D., Marc Elia, Terrance McGuire, Kevin F. McLaughlin, and Ajay Royan.
Directors are elected for one-year terms, with annual elections.
Audit committee and external auditor matters
PricewaterhouseCoopers LLP is recommended for ratification as the independent auditor for the 2026 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Invivyd
- VYD2311 advances toward late-stage COVID-19 prevention, with broad pipeline and market ambitions.IVVD
H.C. Wainwright “HCW @ Home” Series8 Jun 2026 - Antibody-based prevention aims to surpass vaccines in protection, safety, and patient preference.IVVD
Jefferies Global Healthcare Conference 20263 Jun 2026 - Directors were elected and the auditor ratified, with no additional proposals or questions.IVVD
AGM 202619 May 2026 - PEMGARDA revenue up 22% YoY to $13.7M; net loss $41.4M; VYD2311 trial on track for Q3 data.IVVD
Q1 202614 May 2026 - VYD2311 and VMS063 advance in pivotal COVID-19 and measles studies, targeting urgent unmet needs.IVVD
Study update9 Apr 2026 - Six independent directors up for election and auditor ratification headline the annual meeting.IVVD
Proxy filing6 Apr 2026 - Q4 PEMGARDA revenue up 25% YoY to $17.2M; DECLARATION trial fully enrolled for mid-2026 data.IVVD
Q4 20255 Mar 2026 - Strong early uptake of PEMGARDA supports $150–$200M revenue guidance and robust cash outlook.IVVD
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - PEMGARDA launch drove $2.3M Q2 revenue, but cash runway is under one year.IVVD
Q2 20241 Feb 2026